Chengdang Xu

389 Xincun Road
Xincun, 200065, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Exploring Long Noncoding RNA CASC11 as a Biomarker for Bladder Cancer Detection.

Exploring Long Noncoding RNA CASC11 as a Biomarker for Bladder Cancer Detection.

Journal: Asia-Pacific journal of clinical oncology

Published: September 26, 2025

Restraining SRD5A1 combined with BRD4 inhibitor delaying prostate cancer progression by decreasing AR expression.

Restraining SRD5A1 combined with BRD4 inhibitor delaying prostate cancer progression by decreasing AR expression.

Journal: International journal of biological macromolecules

Published: May 16, 2025

Cuproptosis-related gene PROK1 predicts the diagnosis and prognosis of prostate cancer based on multiple machine learning.

Cuproptosis-related gene PROK1 predicts the diagnosis and prognosis of prostate cancer based on multiple machine learning.

Journal: Journal of Cancer

Published: March 10, 2025

Study on the Predictive Value of Renal Resistive Index Combined with β2-Microglobulin in Patients with Urosepsis Complicated with Acute Kidney Injury.

Study on the Predictive Value of Renal Resistive Index Combined with β2-Microglobulin in Patients with Urosepsis Complicated with Acute Kidney Injury.

Journal: Journal of inflammation research

Published: August 24, 2024

Identification of key genes participating in copper-diethyldithiocarbamate-related cell death process and predicting the development of prostate cancer.

Identification of key genes participating in copper-diethyldithiocarbamate-related cell death process and predicting the development of prostate cancer.

Journal: Discover oncology

Published: April 21, 2024

Identification of BBC3 as a novel indicator for predicting prostate cancer development and olaparib resistance.

Identification of BBC3 as a novel indicator for predicting prostate cancer development and olaparib resistance.

Journal: Discover oncology

Published: February 23, 2024

FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer.

FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer.

Journal: International journal of medical sciences

Published: November 04, 2023

Perineural Invasion as a Risk Factor For Soft Tissue Progression in Patients With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Resistance.

Perineural Invasion as a Risk Factor For Soft Tissue Progression in Patients With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Resistance.

Journal: Clinical genitourinary cancer

Published: October 19, 2023

Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel.

Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel.

Journal: Discover oncology

Published: October 16, 2023

Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.

Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.

Journal: BMC medical genomics

Published: August 15, 2023

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression.

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression.

Journal: Cell death discovery

Published: August 13, 2023

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.

Journal: Cell death & disease

Published: August 08, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026